Increased Coagulation in Childhood Obesity

REFERENCES

• Cinaz P. Obezite. Güncel Çocuk Sağlığı. 2008;1(3):289–303.
   Google Scholar
• WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000:894(i–xii):1–253.
   Google Scholar
• Ogden C, Carroll M, Curtin L, Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555.
   PubMed Web of Science ®Google Scholar
• Barlow SE, Dietz WH. Obesity evaluation and treatment: expert committee recommendations. The maternal and child health bureau, health resources and services administration and the department of health and human services. Pediatrics. 1998;102:E29.
   PubMed Web of Science ®Google Scholar
• Weiss R, Dziura J, Burgert TS, Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374.
   PubMed Web of Science ®Google Scholar
• Saraç F, Saydam G, Tüzün M, Obezitede trombosit fonksiyonları. Turkish J Endocrin Metabol. 2003;Suppl 2:69–72.
   Google Scholar
• Anfossi G, Russo I, Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis. 2009;19:440–449.
   PubMed Web of Science ®Google Scholar
• Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev. 2002;3: 85–101.
   PubMedGoogle Scholar
• Nagai N, Hoylaerts MF, Cleuren AC, Obesity promotes injury induced femoral artery thrombosis in mice. Thromb Res. 2008;122:549–555.
   PubMedGoogle Scholar
• Rosito GA, D'Agostino RB, Massaro J, Association between obesity and a prothrombotic state: the framingham offspring study. Thromb Haemost. 2004;91:683–689.
   PubMed Web of Science ®Google Scholar
• Darvall KAL, Sam RC, Silverman SH, Obesity and thrombosis. Eur J Vasc Endovasc Surg. 2007;33:223–233.
   PubMed Web of Science ®Google Scholar
• Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Int Med. 1993;118:956–963.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505.
   PubMed Web of Science ®Google Scholar
• Heinrich J, Balleisen L, Schulte H, Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54–59.
   PubMed Web of Science ®Google Scholar
• Kannel WB, D'Agostino RB, Belanger AJ. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol. 1992;2:457–466.
   Google Scholar
• Rillaerts E, Van Gaal L, Xiang DZ, Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes. 1989;13:7139–7745.
   Google Scholar
• Fanari P, Somazzi R, Nasrawi F, Haemorheological changes in obese adolescents after short-term diet. Int J Obes. 1993;17:487–494.
   Google Scholar
• Avellone G, Di Garbo V, Cordova R, Evaluation of cardiovascular risk factors in overweight and obese subjects. Int Angiol. 1994;13:25–29.
   Google Scholar
• Licata G, Scaglione R, Avellone G, Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Metabolism. 1995;44:1417–1421.
   PubMedGoogle Scholar
• Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost. 2010;36:7–17.
   Google Scholar
• Fritsch P, Kleber M, Rosenkranz A, Haemostatic alterations in overweight children: associations between metabolic syndrome, trombin generation, and fibrinogen levels. Atherosclerosis. 2010;212:650–655.
   PubMed Web of Science ®Google Scholar
• Balleisen L, Bailey J, Epping PH, Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost. 1985;54:475–479.
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Janson PO, Johansson S, Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril. 1994;61:455–460.
   PubMed Web of Science ®Google Scholar
• Cigolini M, Targher G, Bergamo Andreis IA, Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol. 1996;16:368–374.
   PubMed Web of Science ®Google Scholar
• Licata G, Scaglione R, Avellone G, Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Metabolism. 1995;44:1417–1421.
   PubMedGoogle Scholar
• Folsom AR, Qamhieh HT, Wing RR, Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb. 1993;13:162–169.
   PubMed Web of Science ®Google Scholar
• Frankel DS, Meigs JB, Massaro JM, Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study. Circulation. 2008;118:2533–2539.
   PubMed Web of Science ®Google Scholar
• Renné T, Nieswandt B, Gailani D. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis. 2006;36:148–151.
   PubMed Web of Science ®Google Scholar
• Tucker EI, Marzec UM, White TC, Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood. 2009;113:936–944.
   PubMed Web of Science ®Google Scholar
• Bereczky Z, Katona E, Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb. 2003;33:430–437.
   PubMed Web of Science ®Google Scholar
• Gui T, Reheman A, Funkhouser WK, In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice. Thromb Res. 2007;121:225–234.
   PubMed Web of Science ®Google Scholar
• Meade TW, Mellows S, Brozovic M, Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet. 1986;2:533–537.
   PubMed Web of Science ®Google Scholar
• van-Hylckama-Vlieg A, van-der-Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678–3682.
   Google Scholar
• Weltermann A, Eichinger S, Bialonczyk C, The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28–32.
   PubMed Web of Science ®Google Scholar
• Conlan MG, Folsom AR, Finch A, Associations of factor VIII and von Willebrand factor with age, race, gender, and risk factors for atherosclerosis. The atherosclerosis risk in communities (ARIC) study. Thromb Haemost, 1993;70:380–385.
   PubMed Web of Science ®Google Scholar
• Kaye M, Pietiläinen KH, Kotronen A, Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity. 2012;20:88–94.
   PubMed Web of Science ®Google Scholar
• Blann AD, Bushell D, Davies A, von Willebrand factor, the endothelium and obesity. Int J Obes. 1993;17:723–725.
   Google Scholar
• Batist G, Bothe A, Bern M, Low antithrombin III in morbid obesity: return to normal with weight reduction. J Parent Enteral Nutr. 1983;7:447–449.
   Google Scholar
• Rudnicka AR, Rumley A, Lowe GDO, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin d-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation. 2007;115:996–1003.
   PubMed Web of Science ®Google Scholar